Oligodendrocyte Precursor Cells and Multiple Sclerosis from ANA2020 Virtual Meeting

Neurologist Peter Calabresi recaps his presentation, “Oligodendrocyte Precursor Cell Present Antigen and Are Cytotoxic Targets in Inflammatory Demyelination,” from the American Neurological Association 2020 Virtual Meeting. His lab is developing a new model to understand why oligodendrocyte precursor cells (OPCs) might fail to make myelin in the context of multiple sclerosis plaque and the value of identifying transcriptomic profiles of OPCs that are amenable to therapeutic intervention. 

Created by

Johns Hopkins Medicine

Related Presenters

Peter Arthur Calabresi, MD

Peter Arthur Calabresi, MD

Director, Division of Neuroimmunology

Dr. Peter Calabresi serves as the Director of the Multiple Sclerosis Center, focusing on the diagnosis and management of MS. He is the principal investigator on several clinical trials and oversees research projects seeking to create new ...

View full profile